Cannabinoid substances – in the context of the current partial legalisation of cannabis, this somehow sounds like a narcotic. However, many of the 120 or so known cannabinoids are potent painkillers, including delta-9-THC (dronabinol), which doctors prescribe very specifically for certain chronic pains. Because the chemical synthesis used to date is not without its problems, researchers in the BigPharm project are looking for sustainable biotechnological alternatives.
“Our robust yeast can process a wide range of waste streams”
The Munich-based biotech start-up Insempra GmbH is one of the eight winning teams of the SPRIND Challenge "Circular Biomanufacturing". The CEO and founder of Insempra is Jens Klein, who, like his colleague Lin Römer, once played a leading role at the biotech company AMSilk. The company is receiving millions in funding from the Federal Agency for Leap Innovations SPRIND (with 1.5 million euros in the first year) for the BioTreasure project.